This is an archive page. The links are no longer being updated.

Date: Tuesday, April 23, 1996
FOR IMMEDIATE RELEASE
Contact: AHCPR Public Affairs(301)594-1364,Karen Migdail, ext.
174,Salina Prasad, ext. 159

NEW GUIDELINES CHALLENGE ALL CLINICIANS TO HELP SMOKERS QUIT

Clinicians should aggressively help their smoking patients quit, according to new clinical practice guidelines sponsored by HHS' Agency for Health Care Policy and Research. The guidelines released today were developed by a leading panel of smoking cessation experts. They challenge every clinician including doctors, nurses, dentists and others to find out if their patients smoke, repeatedly encourage them to quit, and recommend treatments proven to work.

The panel's recommendations include using the nicotine patch or nicotine gum -- which double the chances of successfully quitting -- combined with a clinician's encouragement and support and practical advice to smokers on how to cope with situations and behavior that make them want to smoke.

"This is good news for the more than 70 percent of adult smokers in the United States who would like to quit," said Douglas B. Kamerow, M.D., M.P.H., AHCPR's director of clinical practice guideline development. "The guidelines are a call to action to clinicians to approach smoking as a chronic condition that is very difficult, but not impossible, to treat."

This is the first time the total body of information on smoking cessation has been analyzed systematically. In developing the guidelines, the panel reviewed over 3,000 scientific articles that addressed the assessment and treatment of tobacco dependence, nicotine addiction, and clinical practice.

"These guidelines not only challenge the way we practice medicine but also can tremendously improve the services we are able to provide smokers who want to quit," said Michael C. Fiore, M.D., M.P.H., chair of the guideline panel and director of the University of Wisconsin's Center for Tobacco Research and Intervention. "While there is no perfect way to quit, clinicians are in a unique position to tailor proven treatments to the particular needs of those patients who want to overcome their nicotine addiction."

Only half the smokers who see a doctor have ever been urged to quit, even though smoking is the single greatest preventable cause of illness and premature death in the United States. People who smoke are at increased risk of heart disease, cancer and other smoking-related illnesses that contribute to over 420,000 deaths a year. Medical costs for smokers are $50 billion annually, with an additional $47 billion for indirect expenses, such as time lost from work and disability.

The AHCPR guidelines recommend that clinicians:

Other recommendations to health care administrators, purchasers and insurers include changing the health care delivery systems to make it a standard practice to identify and treat smokers and other tobacco users.

The guidelines' consumer brochure urges smokers to:

Whenever possible, smoking cessation treatments should be appropriately tailored to ethnic or racial groups. The guidelines also carry recommendations for pregnant women, hospitalized patients and persons with psychological problems. Recommendations also address tobacco prevention and cessation in children and adolescents, and smokeless tobacco products (snuff and chewing tobacco).

No conclusions were drawn about the effectiveness of acupuncture, hypnosis and drug therapies such as clonidine, antidepressants, and anxiolytics/benzodiazepines because of insufficient or inconclusive evidence.

The panel also made no recommendations regarding the use of nicotine nasal sprays and nicotine inhalers. There was limited data on these products. At the time of the panel's deliberations, the products were not licensed for prescription use in the United States. [As the guidelines went to press, the Food and Drug Administration approved the prescription use of nicotine nasal spray.]

AHCPR plans to disseminate the guidelines, cosponsored by the Centers for Disease Control and Prevention, to a wide range of clinicians, smoking cessation specialists, health care administrators, purchasers and insurers. A quick reference guide, pocket guide and consumer version, in English and Spanish, also will be distributed.

The American Medical Association has received an educational grant from the Robert Wood Johnson Foundation to send copies of a pocket guide version of the guidelines to 200,000 primary care doctors.

In addition, today's special tobacco issue of the Journal of the American Medical Association -- the most widely read medical journal in the United States -- features a summary of the smoking cessation guidelines.

The 19-member panel included physicians, nurses, mental health experts, a dentist, a pharmacist, psychologists, an epidemiologist, an educator and a consumer representative.

The panel invited 155 outside professionals to review the document and also made it available for public comment through a notice in the Federal Register. A total of 71 reviewers provided comments.

The guideline publications Smoking Cessation: Quick Reference Guide for Primary Care Clinicians; Smoking Cessation: Quick Reference Guide for Smoking Cessation Specialists; and You Can Quit Smoking: Guide for Consumers are available free of charge from the AHCPR Publications Clearinghouse. Call toll-free 800-358-9295, or write to Smoking Cessation, AHCPR Publications Clearinghouse, P.O. Box 8547, Silver Spring, Md. 20907-8547. They also are available 24 hours a day, 7 days a week, through AHCPR InstantFax, 301-594-2800.

Single and bulk copies of the full guideline, Smoking Cessation: Clinical Practice Guideline, may be purchased from the U.S. Government Printing Office by calling 202-512-1800.

The full guideline, quick reference and consumer guides, and the meta-analysis references will be available on Internet through the AHCPR Home Page. Access the guideline products by using a Web browser, specifying URL www.ahcpr.gov/guide and clicking on "Clinical Practice Guidelines Online."

________________________________________________________________

Note to Editors: The Food and Drug Administration has approved nicotine gum for over-the counter (OTC) use. The nicotine patch may be approved for OTC use by the end of 1996.